Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-01-06 @ 1:32 PM
Study NCT ID:
NCT07042594
Status:
RECRUITING
Last Update Posted:
2025-12-11
First Post:
2025-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD1119 in Healthy Participants
Sponsor:
Suzhou Ribo Life Science Co. Ltd.